Citations (81)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Cecilia Napodano, MariaPaola Marino, Annunziata Stefanile, Krizia Pocino, Roberto Scatena, Francesca Gulli, Gian Lodovico Rapaccini, Stefano Delli Noci, Giovanna Capozio, Donato Rigante & Umberto Basile. (2021) Immunological Role of IgG Subclasses. Immunological Investigations 50:4, pages 427-444.
Read now
Read now
Christopher Pleyer, Clare Sun, Sanjal Desai, Inhye E. Ahn, Xin Tian, Pia Nierman, Susan Soto, Jeanine Superata, Janet Valdez, Jennifer Lotter & Adrian Wiestner. (2020) Reconstitution of humoral immunity and decreased risk of infections in patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors. Leukemia & Lymphoma 61:10, pages 2375-2382.
Read now
Read now
Marina Deodato, Anna Maria Frustaci, Giulia Zamprogna, Roberto Cairoli, Marco Montillo & Alessandra Tedeschi. (2019) Ibrutinib for the treatment of chronic lymphocytic leukemia. Expert Review of Hematology 12:5, pages 273-284.
Read now
Read now
Tamar Tadmor, Manfred Welslau & Iwona Hus. (2018) A review of the infection pathogenesis and prophylaxis recommendations in patients with chronic lymphocytic leukemia. Expert Review of Hematology 11:1, pages 57-70.
Read now
Read now
Jasleen K. Randhawa & Alessandra Ferrajoli. (2016) A review of supportive care and recommended preventive approaches for patients with chronic lymphocytic leukemia. Expert Review of Hematology 9:3, pages 235-244.
Read now
Read now
Anat Gafter-Gvili, Elena Ribakovsky, Nadav Mizrahi, Abraham Avigdor, Ariel Aviv, Liat Vidal, Ron Ram, Chava Perry, Irit Avivi, Meirav Kedmi, Arnon Nagler, Pia Raanani & Ronit Gurion. (2016) Infections associated with bendamustine containing regimens in hematological patients: a retrospective multi-center study. Leukemia & Lymphoma 57:1, pages 63-69.
Read now
Read now
Benjamin W. Teh & Monica A. Slavin. (2014) More than a feeling: new approach required for assessing immunosuppression. Leukemia & Lymphoma 55:5, pages 975-976.
Read now
Read now
Catherine Cordonnier, Diana Averbuch, Sébastien Maury & Dan Engelhard. (2014) Pneumococcal immunization in immunocompromised hosts: where do we stand?. Expert Review of Vaccines 13:1, pages 59-74.
Read now
Read now
Tobias Svensson, Martin Höglund & Honar Cherif. (2013) Clinical significance of serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukemia. Scandinavian Journal of Infectious Diseases 45:7, pages 537-542.
Read now
Read now
Jane A. Freeman, Kyle R. Crassini, O. Giles Best, Cecily J. Forsyth, Naomi J. Mackinlay, Ping Han, William Stevenson & Stephen P. Mulligan. (2013) Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia. Leukemia & Lymphoma 54:1, pages 99-104.
Read now
Read now
S. Molica. (2005) Quality of life in chronic lymphocytic leukemia: A neglected issue. Leukemia & Lymphoma 46:12, pages 1709-1714.
Read now
Read now
Marjatta Sinisalo, Janne Aittoniemi, Tomi Koski, Gerard Tobin, Ulf Thunberg, Christer Sundström, Richard Rosenquist, Helena Käyhty & Juhani Vilpo. (2004) Similar Humoral Immunity Parameters in Chronic Lymphocytic Leukemia Patients Independent of VH Gene Mutation Status. Leukemia & Lymphoma 45:12, pages 2451-2454.
Read now
Read now
Marjatta Sinisalo, Janne Aittoniemi, Helena Käyhty & Juhani Vilpo. (2003) Vaccination Against Infections in Chronic Lymphocytic Leukemia. Leukemia & Lymphoma 44:4, pages 649-652.
Read now
Read now
Marjatta Sinisalo, Janne Aittoniemi, Helena Käyhty & Juhani Vilpo. (2002) Haemophilus Influenzae Type b (Hib) Antibody Concentrations and Vaccination Responses in Patients with Chronic Lymphocytic Leukaemia: Predicting Factors for Response. Leukemia & Lymphoma 43:10, pages 1967-1969.
Read now
Read now
Anna Candoni, Mario Tiribelli, Francesco Zaja, Daniela Damiani, Federico Silvestri & Renato Fanin. (2002) Nocardiosis with Favourable Clinical Outcome in Progressive B-chronic Lymphocytic Leukaemia. Leukemia & Lymphoma 43:9, pages 1893-1894.
Read now
Read now
J. Aittoniemi, A. Miettinen, S. Lainf, M. Sinisalo, P. Laippala, L. Vilpo & J. Vilpo. (1999) Opsonising Immunoglobulins and Mannan-Binding Lectin in Chronic Lymphocytic Leukemia. Leukemia & Lymphoma 34:3-4, pages 381-385.
Read now
Read now
M. Itälä, T T. Pelliniemi, K. Remes, S. Vanhatalo & O. Vainio. (1998) Long-Term Treatment with GM-CSF in Patients with Chronic Lymphocytic Leukemia and Recurrent Neutropenic Infections. Leukemia & Lymphoma 32:1-2, pages 165-174.
Read now
Read now
Articles from other publishers (64)
Maria Kislova, Andrei Petrenko, Elena A. Dmitrieva, Alexander Milenkin, Konstantin E. Nikitin, Vadim V. Ptushkin, Alexey V. Shabunin & Eugene A. Nikitin. (2023) Significant reduction in the incidence of non‐coronavirus infections in patients with chronic lymphocytic leukemia on ibrutinib and venetoclax treatment during the COVID‐19 pandemic: An additional benefit of lockdown. Hematological Oncology.
Crossref
Crossref
Jennifer Edelmann, Jitka Malcikova & John C. Riches. (2023) Opinion: What defines high-risk CLL in the post-chemoimmunotherapy era?. Frontiers in Oncology 13.
Crossref
Crossref
Maria Stefania Infante, Ana Fernández‐Cruz, Lucia Núñez, Cecilia Carpio, Ana Jiménez‐Ubieto, Javier López‐Jiménez, Lourdes Vásquez, Raquel Del Campo, Samuel Romero, Carmen Alonso, Daniel Morillo, Margarita Prat, José Luis Plana, Paola Villafuerte, Gabriela Bastidas, Ana Bocanegra, Ángel Serna, Rodrigo De Nicolás, Juan Marquet, Carmen Mas‐Ochoa, Raúl Cordoba, Julio García‐Suárez, Alessandra Comai, Xavier Martín, Mariana Bastos‐Oreiro, Cristina Seri, Belén Navarro‐Matilla, Armando López‐Guillermo, Joaquín Martínez‐López, José Ángel Hernández‐Rivas, Isabel Ruiz‐Camps & Carlos Grande. (2021) Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A multicentric real‐world study. Cancer Medicine 10:21, pages 7629-7640.
Crossref
Crossref
Monica Else, Stuart J. Blakemore, Jonathan C. Strefford & Daniel Catovsky. (2021) The association between deaths from infection and mutations of the BRAF, FBXW7, NRAS and XPO1 genes: a report from the LRF CLL4 trial. Leukemia 35:9, pages 2563-2569.
Crossref
Crossref
Malgorzata McMasters, Barbra M. Blair, Hillard M. Lazarus & Carolyn D. Alonso. (2021) Casting a wider protective net: Anti-infective vaccine strategies for patients with hematologic malignancy and blood and marrow transplantation. Blood Reviews 47, pages 100779.
Crossref
Crossref
Lisa Rohrbacher, Bettina Brauchle, Ana Ogrinc Wagner, Michael von Bergwelt-Baildon, Veit L. Bücklein & Marion Subklewe. (2021) The PI3K∂-Selective Inhibitor Idelalisib Induces T- and NK-Cell Dysfunction Independently of B-Cell Malignancy-Associated Immunosuppression. Frontiers in Immunology 12.
Crossref
Crossref
Jennifer A. Whitaker, Sameer A. Parikh, Tait D. Shanafelt, Neil E. Kay, Richard B. Kennedy, Diane E. Grill, Krista M. Goergen, Timothy G. Call, Saad S. Kendarian, Wei Ding & Gregory A. Poland. (2021) The humoral immune response to high-dose influenza vaccine in persons with monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL). Vaccine 39:7, pages 1122-1130.
Crossref
Crossref
Michelle Kwok, John Lin & Jean-Pierre Routy. (2021) Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia. BMJ Case Reports 14:1, pages e235981.
Crossref
Crossref
Mesut Göçer & Erdal Kurtoğlu. (2020) Safety and efficacy analysis of ibrutinib in 32 patients with CLL and various B-cell lymphomas: real-world data from a single-center study in Turkey. BLOOD RESEARCH 55:4, pages 206-212.
Crossref
Crossref
Ewelina Grywalska, Monika Zaborek, Jakub Łyczba, Rafał Hrynkiewicz, Dominika Bębnowska, Rafał Becht, Barbara Sosnowska-Pasiarska, Jolanta Smok-Kalwat, Marcin Pasiarski, Stanisław Góźdź, Jacek Roliński & Paulina Niedźwiedzka-Rystwej. (2020) Chronic Lymphocytic Leukemia-Induced Humoral Immunosuppression: A Systematic Review. Cells 9:11, pages 2398.
Crossref
Crossref
Hans-Jürgen Laws, Ulrich Baumann, Christian Bogdan, Gerd Burchard, Maximilian Christopeit, Jane Hecht, Ulrich Heininger, Inken Hilgendorf, Winfried Kern, Kerstin Kling, Guido Kobbe, Wiebe Külper, Thomas Lehrnbecher, Roland Meisel, Arne Simon, Andrew Ullmann, Maike de Wit & Fred Zepp. (2020) Impfen bei Immundefizienz. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 63:5, pages 588-644.
Crossref
Crossref
Mulder, Wahlin, Österborg & Palma. (2019) Targeting the Immune Microenvironment in Lymphomas of B-Cell Origin: From Biology to Clinical Application. Cancers 11:7, pages 915.
Crossref
Crossref
E.A. Dmitrieva, Evgenii Aleksandrovich Nikitin, E.E. Markova, N.Yu. Dmitrieva & V.V. Ptushkin. (2019) Infections in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib: Incidence and Predisposing Factors. Clinical oncohematology 12:4, pages 78-88.
Crossref
Crossref
Nhora Silva, Natalia Calvache, Elizabeth Arrieta, Juan Carlos Bravo, Camilo Salazar, Joaquín Rosales, Francisco Jaramillo & Juan Guillermo Restrepo. (2018) Histoplasmosis diseminada como manifestación inicial del linfoma linfocítico de células pequeñas. Biomédica 38:3, pages 298-302.
Crossref
Crossref
Talal Hilal, Juan C. Gea-Banacloche & Jose F. Leis. (2018) Chronic lymphocytic leukemia and infection risk in the era of targeted therapies: Linking mechanisms with infections. Blood Reviews 32:5, pages 387-399.
Crossref
Crossref
Tobias Svensson, Magdalena Kättström, Ylva Hammarlund, Daniel Roth, P.-O. Andersson, Magnus Svensson, Ingmar Nilsson, Lars Rombo, Honar Cherif & Eva Kimby. (2018) Pneumococcal conjugate vaccine triggers a better immune response than pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia A randomized study by the Swedish CLL group. Vaccine 36:25, pages 3701-3707.
Crossref
Crossref
Tadahiro Honda, Yasuo Aota, Yuko Okuda & Akihiko Gotoh. (2018) Severe acute hepatic failure in older adults with treatment-naïve small lymphocytic lymphoma. Geriatrics & Gerontology International 18:4, pages 648-650.
Crossref
Crossref
Kyle R. Crassini, Eva Zhang, Shalini Balendran, Jane A. Freeman, O. Giles Best, Cecily J. Forsyth, Naomi J. Mackinlay, Ping Han, William S. Stevenson & Stephen P. Mulligan. (2018) Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment‐free and overall survival in Chronic Lymphocytic Leukaemia. British Journal of Haematology 181:1, pages 97-101.
Crossref
Crossref
Jennifer A. Woyach. (2018) What is the optimal management of older CLL patients?. Best Practice & Research Clinical Haematology 31:1, pages 83-89.
Crossref
Crossref
Helen E. Speedy, Daniel Catovsky & Richard S. Houlston. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood
69
77
.
Philip Bright & Alex Richter. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences
1
7
.
Tom MunyerLauren Levine Ooka, Bradley Yelvington & Ryan Miller. 2017. PharmacotherapyFirst: A Multimedia Learning Resource. PharmacotherapyFirst: A Multimedia Learning Resource.
P. Kralickova, J. Kuhnova, O. Soucek, P. Vodarek, P. Zak, M. Simkovic, M. Motyckova, L. Smolej, E. Mala, C. Andrys, J. Krejsek & V. Thon. (2017) Antibodies against Pneumococcal Capsular Polysaccharides and Natural Anti-Galactosyl (Alpha-Gal) in Patients with Humoral Immunodeficiencies. Journal of Immunology Research 2017, pages 1-8.
Crossref
Crossref
C da Cunha-Bang, J Simonsen, K Rostgaard, C Geisler, H Hjalgrim & C U Niemann. (2016) Improved survival for patients diagnosed with chronic lymphocytic leukemia in the era of chemo-immunotherapy: a Danish population-based study of 10455 patients. Blood Cancer Journal 6:11, pages e499-e499.
Crossref
Crossref
Christian Kjellander, Magnus Björkholm, Owe Källman, Christian G. Giske, Caroline E. Weibull, Thorvardur J. Löve, Ola Landgren & Sigurdur Y. Kristinsson. (2016) Bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal single-center study. Annals of Hematology 95:6, pages 871-879.
Crossref
Crossref
Sarah Wall & Jennifer A. Woyach. (2016) Chronic Lymphocytic Leukemia and Other Lymphoproliferative Disorders. Clinics in Geriatric Medicine 32:1, pages 175-189.
Crossref
Crossref
V.I. Bakhtina, I.V. Demko, A.N. Narkevich & D.S. Gushchin. (2016) Factors Affecting Course and Outcome of Chronic Lymphocytic Leukemia: Data from Hematological Hospitals of Krasnoyarsk Region. Clinical oncohematology 9:4, pages 413-419.
Crossref
Crossref
Teresa Jurado-Camino, Raúl Córdoba, Laura Esteban-Burgos, Enrique Hernández-Jiménez, Victor Toledano, Jose-Angel Hernandez-Rivas, Elena Ruiz-Sainz, Teresa Cobo, María Siliceo, Rebeca Perez de Diego, Cristobal Belda, Carolina Cubillos-Zapata & Eduardo López-Collazo. (2015) Chronic Lymphocytic Leukemia: A Paradigm of Innate Immune Cross-Tolerance. The Journal of Immunology 194:2, pages 719-727.
Crossref
Crossref
O Middleton, E Cosimo, E Dobbin, A M McCaig, C Clarke, A M Brant, M T Leach, A M Michie & H Wheadon. (2014) Complement deficiencies limit CD20 monoclonal antibody treatment efficacy in CLL. Leukemia 29:1, pages 107-114.
Crossref
Crossref
Corentin Orvain, Alexandra Ducancelle, Caroline Eymerit-Morin, Marie-Christine Rousselet, Frederic Oberti, Mathilde Hunault-Berger & Aline Tanguy-Schmidt. (2015) Severe viral hepatitis in a patient with chronic lymphocytic leukemia (CLL) complicated with autoimmune hemolytic anemia (AIHA), treated with steroids. Journal of Clinical Virology 62, pages 66-68.
Crossref
Crossref
Marcin Pasiarski, Jacek Rolinski, Ewelina Grywalska, Agnieszka Stelmach-Goldys, Izabela Korona-Glowniak, Stanislaw Gozdz, Iwona Hus & Anna Malm. (2014) Antibody and Plasmablast Response to 13-Valent Pneumococcal Conjugate Vaccine in Chronic Lymphocytic Leukemia Patients – Preliminary Report. PLoS ONE 9:12, pages e114966.
Crossref
Crossref
Paolo F. Caimi & Marcos de Lima. (2014) Genetic polymorphisms, chronic lymphocytic leukemia, and the future: are we there yet???See paper by Holanda K et al. on pages 29?34.. Revista Brasileira de Hematologia e Hemoterapia 36:1, pages 5-6.
Crossref
Crossref
Dariusz Wołowiec. (2013) Powikłania infekcyjne i autoimmunologiczne w przewlekłej białaczce limfocytowej. Acta Haematologica Polonica 44:3, pages 188-195.
Crossref
Crossref
Jacek Roli?ski, Marcin Pasiarski, Iwona Hus & Stanis?aw G??d?. (2013) Profilaktyka i leczenie zaka?e? u chorych na przewlek?? bia?aczk? limfocytow?. Acta Haematologica Polonica 44:2, pages 99-103.
Crossref
Crossref
Emili Montserrat. 2013. Lymphoma. Lymphoma
65
82
.
Dalemari Crowther-Swanepoel, Daniel Catovsky & Richard S. Houlston. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood
63
69
.
Nupur Bhattacharya, Susanne Diener, Irina S. Idler, Judith Rauen, Sarah Häbe, Hauke Busch, Annett Habermann, Thorsten Zenz, Hartmut Döhner, Stephan Stilgenbauer & Daniel Mertens. (2011) Nurse-like cells show deregulated expression of genes involved in immunocompetence. British Journal of Haematology 154:3, pages 349-356.
Crossref
Crossref
Penelope J. HarrisMichael B. Osswald. (2010) Pasteurella Multocida Epiglottitis: A Review and Report of a New Case with Associated Chronic Lymphocytic Leukemia. Ear, Nose & Throat Journal 89:12, pages E4-E7.
Crossref
Crossref
J. Monserrat Sanz, C. Sánchez Mingo, D. Díaz Martín, J. Sánchez Escribano, E. Reyes Martín, A. Prieto Martín & M. Álvarez-Mon Soto. (2009) Inmunodeficiencias primarias y secundarias. Medicine - Programa de Formación Médica Continuada Acreditado 10:28, pages 1909-1920.
Crossref
Crossref
Elias Anaissie. 2008. Chronic Lymphocytic Leukemia. Chronic Lymphocytic Leukemia
261
292
.
Mollie Moran, Mary Browning & Emma Buckby. (2007) Nursing Guidelines for Managing Infections in Patients With Chronic Lymphocytic Leukemia. Clinical Journal of Oncology Nursing 11:6, pages 914-924.
Crossref
Crossref
Marjatta Sinisalo, Juhani Vilpo, Maija Itälä, Merja Väkeväinen, Jyrki Taurio & Janne Aittoniemi. (2007) Antibody response to 7-valent conjugated pneumococcal vaccine in patients with chronic lymphocytic leukaemia. Vaccine 26:1, pages 82-87.
Crossref
Crossref
Barbara F. Eichhorst, Raymonde Busch, Carmen Schweighofer, Clemens M. Wendtner, Berthold Emmerich & Michael Hallek. (2007) Due to low infection rates no routine anti-infective prophylaxis is required in younger patients with chronic lymphocytic leukaemia during fludarabine-based first line therapy. British Journal of Haematology 136:1, pages 63-72.
Crossref
Crossref
Manish Butte. 2007. Comprehensive Pediatric Hospital Medicine. Comprehensive Pediatric Hospital Medicine
870
873
.
M. Palma, P. Kokhaei, J. Lundin, A. Choudhury, H. Mellstedt & A. Österborg. (2006) The biology and treatment of chronic lymphocytic leukemia. Annals of Oncology 17, pages x144-x154.
Crossref
Crossref
Sebastian Francis, Mamatha Karanth, Guy Pratt, Jane Starczynski, Laura Hooper, Chris Fegan, Chris Pepper, David Valcarcel, Donald W. Milligan & Julio Delgado. (2006)
The effect of immunoglobulin
V
H
gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemia
. Cancer 107:5, pages 1023-1033.
Crossref
Crossref
Farhad Ravandi & Susan O’Brien. (2005) Immune defects in patients with chronic lymphocytic leukemia. Cancer Immunology, Immunotherapy 55:2, pages 197-209.
Crossref
Crossref
Emili Montserrat & Elias Campo. 2006. The Lymphomas. The Lymphomas
406
414
.
Farhad Ravandi & Susan O’Brien. (2005) Infections associated with purine analogs and monoclonal antibodies. Blood Reviews 19:5, pages 253-273.
Crossref
Crossref
P. Kokhaei, M. Palma, H. Mellstedt & A. Choudhury. (2005) Biology and treatment of chronic lymphocytic leukemia. Annals of Oncology 16, pages ii113-ii123.
Crossref
Crossref
Enrica Orsini, Alessia Pasquale, Roberta Maggio, Elisabetta Calabrese, Francesca Romana Mauro, Elena Giammartini, Anna Guarini & Robin Foa. (2004)
Phenotypic and functional characterization of monocyte-derived dendritic cells in chronic lymphocytic leukaemia patients: influence of neoplastic CD19
+
cells
in vivo
and
in vitro
. British Journal of Haematology 125:6, pages 720-728.
Crossref
Crossref
D. Oscier, C. Fegan, P. Hillmen, T. Illidge, S. Johnson, P. Maguire, E. Matutes & D. Milligan. (2004) Guidelines on the diagnosis and management of chronic lymphocytic leukaemia. British Journal of Haematology 125:3, pages 294-317.
Crossref
Crossref
Wolfgang Hiddemann, Heinz Huber & Claus R. BartramB. Emmerich. 2004. Die Onkologie. Die Onkologie
1975
2000
.
Francesc Bosch & Emili Montserrat. 2004. Chronic Lymphocytic Leukemia. Chronic Lymphocytic Leukemia
201
215
.
Manfred Hensel, Martin Kornacker, Sophie Yammeni, Gerlinde Egerer & Anthony D. Ho. (2003) Disease activity and pretreatment, rather than hypogammaglobulinaemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukaemia. British Journal of Haematology 122:4, pages 600-606.
Crossref
Crossref
Susan N. O’Brien, Nicole M.A. Blijlevens, Tahsine H. Mahfouz & Elias J. Anaissie. (2003) Infections in Patients with Hematological Cancer: Recent Developments. Hematology 2003:1, pages 438-472.
Crossref
Crossref
Vicki A. MorrisonKanti R. RaiBercedis L. PetersonJonathan E. KolitzLaurence EliasFrederick R. AppelbaumJohn D. HinesLois ShepherdRobert E. MartellRichard A. LarsonCharles A. Schiffer. (2001) Impact of Therapy With Chlorambucil, Fludarabine, or Fludarabine Plus Chlorambucil on Infections in Patients With Chronic Lymphocytic Leukemia: Intergroup Study Cancer and Leukemia Group B 9011. Journal of Clinical Oncology 19:16, pages 3611-3621.
Crossref
Crossref
Marjatta Sinisalo, Janne Aittoniemi, Petri Oivanen, Helena Käyhty, Rose‐Marie Ölander & Juhani Vilpo. (2002) Response to vaccination against different types of antigens in patients with chronic lymphocytic leukaemia. British Journal of Haematology 114:1, pages 107-110.
Crossref
Crossref
Gerlinde Egerer, Manfred Hensel & Anthony D. Ho. (2001) Infectious complications in chronic lymphoid malignancy. Current Treatment Options in Oncology 2:3, pages 237-244.
Crossref
Crossref
Sotirios Tsiodras, George Samonis, Michael J. Keating & Dimitrios P. Kontoyiannis. (2000) Infection and Immunity in Chronic Lymphocytic Leukemia. Mayo Clinic Proceedings 75:10, pages 1039-1054.
Crossref
Crossref
John P. T. Higgins & Roger A. Warnke. (1999) Herpes lymphadenitis in association with chronic lymphocytic leukemia. Cancer 86:7, pages 1210-1215.
Crossref
Crossref
Henrik Gregersen, Kreesten Meldgaard Madsen, Henrik Toft Sørensen, Henrik Carl Schønheyder, Jenna Sailing Ibsen & Jens Frederik Dahlerup. (2009) The risk of bacteremia in patients with monoclonal gammopathy of undetermined significance. European Journal of Haematology 61:2, pages 140-144.
Crossref
Crossref
ROBERT SCHAEDEL & MORTON H. GOLDBERG. (1997) CHRONIC LYMPHOCYTIC LEUKEMIA OF B-CELL ORIGIN: ORAL MANIFESTATIONS AND DENTAL TREATMENT PLANNING. The Journal of the American Dental Association 128:2, pages 206-210.
Crossref
Crossref
Ciril Rozman & Emilio Montserrat. (1995) Chronic Lymphocytic Leukemia. New England Journal of Medicine 333:16, pages 1052-1057.
Crossref
Crossref